Fig. 2From: The “Intermediate” CD14 + CD16 + monocyte subpopulation plays a role in IVIG responsiveness of children with Kawasaki diseaseSerial measurement of CD14 + CD16 + intermediate monocytes in IVIG- responsive and IVIG-resistant groups. The time of measurements were D0 (acute phase, at diagnosis, before IVIG infusion), D2 (acute phase, after resolution of fever, after IVIG infusion) and D56 (convalescent phase, 2 months after diagnosis). * <0.01Back to article page